Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03444961 · ClinicalTrials.gov registry record · NA

Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis

A NA study of Retinitis Pigmentosa, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT03444961 is a NA study of Retinitis Pigmentosa that has completed, run by The Cleveland Clinic. The registered enrollment target is 4 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03444961, a NA study of Retinitis Pigmentosa, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the computer assisted rehabilitation environment (CAREN) system for Argus recipients.

Conditions Studied

Interventions

  • DEVICE CAREN system training

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2018-01-30
Est. Completion 2018-06-20
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03444961

The ClinicalTrials.gov registry entry for NCT03444961 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (98% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which CAREN system training is the first listed.

NCT03444961 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03444961 about?

NCT03444961 is a clinical study titled "Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis". The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the computer assisted rehabilitation environment (CAREN) system for Argus recipients.

What is the current status of trial NCT03444961?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2018-01-30. Estimated completion is 2018-06-20.

What conditions does trial NCT03444961 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT03444961?

The interventions under investigation include: CAREN system training (DEVICE).

Who is sponsoring clinical trial NCT03444961?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03444961 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.